Walter Reinisch Selected Research

Infliximab (Remicade)

3/2024	Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn's disease and ulcerative colitis included in randomised controlled trials.
2/2024	Switching from intravenous to subcutaneous infliximab maintenance therapy in inflammatory bowel disease: Post hoc longitudinal analysis of a randomized trial.
10/2023	Baseline Patient-reported Symptoms Less Predictive Than MM-SES-CD for Endoscopic Remission in Crohn's Disease.
4/2023	Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial.
1/2023	The Performance of the Rutgeerts Score, SES-CD, and MM-SES-CD for Prediction of Postoperative Clinical Recurrence in Crohn's Disease.
1/2023	Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study.
1/2023	Comparative Efficacy of Infliximab vs Ustekinumab for Maintenance of Clinical Response in Biologic Naïve Crohn's Disease.
6/2022	Model Informed Precision Dosing Tool Forecasts Trough Infliximab and Associates with Disease Status and Tumor Necrosis Factor-Alpha Levels of Inflammatory Bowel Diseases.
6/2022	Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis.
5/2022	Correction to: Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Walter Reinisch Research Topics

Disease

108	Crohn Disease (Crohn's Disease) 03/2024 - 07/2002
95	Ulcerative Colitis 04/2024 - 12/2005
71	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2024 - 08/2005
23	Infections 12/2023 - 10/2009
16	Necrosis 03/2023 - 02/2003
12	Inflammation (Inflammations) 01/2023 - 09/2006
10	COVID-19 09/2022 - 01/2020
9	Fistula 02/2024 - 01/2004
9	Neoplasms (Cancer) 01/2022 - 11/2002
8	Body Weight (Weight, Body) 02/2024 - 01/2004
8	Hemorrhage 12/2023 - 12/2005
7	Ulcer 01/2023 - 04/2012
7	Rheumatoid Arthritis 01/2023 - 06/2017
6	Colitis 07/2023 - 10/2005
4	Rheumatic Diseases (Rheumatism) 01/2023 - 01/2022
4	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2022 - 07/2013
4	Tuberculosis (Tuberculoses) 01/2018 - 10/2009
4	Drug-Related Side Effects and Adverse Reactions 01/2016 - 06/2010
3	Pouchitis 01/2023 - 06/2015
3	Psoriatic Arthritis 01/2022 - 01/2020
3	Ankylosing Spondylitis 01/2021 - 06/2017
3	Hepatocellular Carcinoma (Hepatoma) 02/2003 - 11/2002
2	Proctitis 04/2024 - 11/2022
2	Respiratory Tract Infections (Respiratory Tract Infection) 12/2023 - 01/2022
2	Nasopharyngitis 12/2023 - 01/2022
2	Abdominal Pain (Pain, Abdominal) 10/2023 - 10/2015
2	Herpes Zoster 05/2023 - 01/2017
2	Opportunistic Infections (Opportunistic Infection) 03/2023 - 05/2012
2	Iron Deficiencies 01/2023 - 01/2015
2	Severe Acute Respiratory Syndrome 01/2023 - 01/2021
2	Fibrosis (Cirrhosis) 01/2023 - 12/2012
2	Arthralgia (Joint Pain) 01/2022 - 01/2018
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 01/2020
2	Skin Neoplasms (Skin Cancer) 01/2022 - 01/2017
2	Pulmonary Embolism 01/2022 - 11/2019
2	Pathologic Constriction (Stenosis) 10/2021 - 01/2018
2	Arthritis (Polyarthritis) 01/2021 - 01/2018
2	Venous Thrombosis (Deep-Vein Thrombosis) 12/2020 - 11/2019
2	Disease Progression 01/2020 - 07/2014
2	Heart Failure 01/2018 - 01/2014
2	Bacterial Infections (Bacterial Infection) 01/2018 - 08/2013

Drug/Important Bio-Agent (IBA)

48	Infliximab (Remicade)FDA Link 03/2024 - 01/2004
25	Adalimumab (Humira)FDA Link 01/2024 - 06/2011
19	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2023 - 04/2010
18	Monoclonal AntibodiesIBA 12/2023 - 01/2004
16	vedolizumabIBA 03/2024 - 08/2017
16	C-Reactive ProteinIBA 12/2021 - 01/2009
15	tofacitinibIBA 01/2024 - 01/2017
15	Biomarkers (Surrogate Marker)IBA 04/2023 - 01/2009
12	SteroidsIBA 07/2023 - 07/2002
12	Immunosuppressive Agents (Immunosuppressants)IBA 04/2023 - 06/2009
12	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2022 - 01/2004
12	Azathioprine (Imuran)FDA LinkGeneric 10/2021 - 10/2005
11	Tumor Necrosis Factor InhibitorsIBA 01/2023 - 12/2012
11	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2023 - 12/2012
10	Ustekinumab (CNTO 1275)FDA Link 01/2024 - 01/2018
10	Janus Kinase InhibitorsIBA 01/2024 - 01/2017
10	golimumab FDA Link 07/2023 - 01/2014
9	Mesalamine (Mesalazine)FDA LinkGeneric 10/2023 - 10/2003
7	ontamalimabIBA 12/2023 - 01/2017
6	CytokinesIBA 05/2022 - 11/2002
6	AntibodiesIBA 01/2020 - 10/2003
5	CT-P13IBA 02/2024 - 01/2015
5	IronIBA 01/2023 - 07/2013
5	Thioguanine (Tioguanine)FDA Link 03/2015 - 08/2005
4	upadacitinibIBA 05/2023 - 01/2020
4	2-mercaptopurineIBA 01/2021 - 02/2012
4	LigandsIBA 08/2018 - 11/2002
3	GLPG0634IBA 02/2024 - 01/2023
3	Biosimilar PharmaceuticalsIBA 01/2024 - 01/2021
3	Cell Adhesion Molecule-1IBA 12/2023 - 01/2018
3	mirikizumabIBA 11/2023 - 01/2023
3	IntegrinsIBA 03/2023 - 01/2018
3	VaccinesIBA 01/2023 - 01/2018
3	InterleukinsIBA 01/2023 - 12/2012
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 05/2008
3	Prostaglandins AIBA 05/2022 - 04/2016
3	Immunologic Factors (Immunomodulators)IBA 05/2021 - 11/2013
3	Serum AlbuminIBA 01/2021 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 11/2002
3	AlbuminsIBA 09/2019 - 07/2015
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2016 - 10/2010
3	Interferon-gamma (Interferon, gamma)IBA 02/2010 - 11/2002
2	guselkumabIBA 12/2023 - 01/2022
2	Messenger RNA (mRNA)IBA 05/2022 - 01/2022
2	etrolizumabIBA 01/2022 - 01/2021
2	Toll-Like Receptor 9IBA 12/2020 - 10/2018
2	cobitolimodIBA 12/2020 - 10/2018
2	Alkaline PhosphataseIBA 01/2020 - 01/2017
2	Cell Adhesion MoleculesIBA 10/2018 - 08/2018

Therapy/Procedure

94	Therapeutics 03/2024 - 11/2002
8	Colectomy 07/2023 - 10/2009
7	Biological Therapy 01/2024 - 04/2010
4	Investigational Therapies (Experimental Therapy) 07/2023 - 01/2014
4	Fecal Microbiota Transplantation 10/2017 - 10/2013
3	Remission Induction 07/2023 - 01/2017
2	Aftercare (After-Treatment) 11/2022 - 10/2009
2	Mechanical Ventilators (Ventilator) 01/2021 - 01/2020
2	Enema (Enemas) 08/2018 - 10/2013